TCL Archive NCCN in Transition: New Strategy to Examine Role of Informatics, Revenue Sources and International Programs June 15, 2012
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive In Brief: Million, Donaldson Head ASTRO; James Weese Moves To Presbyterian; Ginder Replaces Kennedy November 9, 1990
TCL Archive DCT Board Approves More Than $25 Million In Contract Recompetitions, Two New Contracts February 23, 1990
